JP2024506321A5 - - Google Patents
Info
- Publication number
- JP2024506321A5 JP2024506321A5 JP2023547808A JP2023547808A JP2024506321A5 JP 2024506321 A5 JP2024506321 A5 JP 2024506321A5 JP 2023547808 A JP2023547808 A JP 2023547808A JP 2023547808 A JP2023547808 A JP 2023547808A JP 2024506321 A5 JP2024506321 A5 JP 2024506321A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163147676P | 2021-02-09 | 2021-02-09 | |
| US63/147,676 | 2021-02-09 | ||
| PCT/US2022/015652 WO2022173745A1 (en) | 2021-02-09 | 2022-02-08 | Antibodies against respiratory syncytial virus, human metapneumovirus and pneumonia virus of mice and methods of using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024506321A JP2024506321A (ja) | 2024-02-13 |
| JP2024506321A5 true JP2024506321A5 (enExample) | 2025-02-19 |
| JP7880344B2 JP7880344B2 (ja) | 2026-06-25 |
Family
ID=80461207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023547808A Active JP7880344B2 (ja) | 2021-02-09 | 2022-02-08 | 呼吸器合胞体ウイルスおよび他のパラミクソウイルスに対する抗体およびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240101648A1 (enExample) |
| EP (1) | EP4291575A1 (enExample) |
| JP (1) | JP7880344B2 (enExample) |
| CN (1) | CN117136197A (enExample) |
| BR (1) | BR112023015900A2 (enExample) |
| CA (1) | CA3210502A1 (enExample) |
| TW (1) | TW202246317A (enExample) |
| WO (1) | WO2022173745A1 (enExample) |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| EP0604580A1 (en) | 1991-09-19 | 1994-07-06 | Genentech, Inc. | EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab') 2? ANTIBODIES |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| US6833268B1 (en) | 1999-06-10 | 2004-12-21 | Abgenix, Inc. | Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| KR100797667B1 (ko) | 1999-10-04 | 2008-01-23 | 메디카고 인코포레이티드 | 외래 유전자의 전사를 조절하는 방법 |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| WO2004076677A2 (en) | 2003-02-26 | 2004-09-10 | Institute For Research In Biomedicine | Monoclonal antibody production by ebv transformation of b cells |
| EP3342782B1 (en) * | 2004-07-15 | 2022-08-17 | Xencor, Inc. | Optimized fc variants |
| WO2008042814A2 (en) | 2006-09-29 | 2008-04-10 | California Institute Of Technology | Mart-1 t cell receptors |
| KR102149069B1 (ko) * | 2012-03-20 | 2020-08-28 | 후맙스 바이오메드 에스에이 | Rsv, mpv 및 pvm를 중화하는 항체 및 이의 용도 |
| US11267899B2 (en) | 2015-05-13 | 2022-03-08 | Zumutor Biologics Inc. | Afucosylated protein, cell expressing said protein and associated methods |
| JO3555B1 (ar) * | 2015-10-29 | 2020-07-05 | Merck Sharp & Dohme | جسم مضاد يبطل فعالية فيروس الالتهاب الرئوي البشري |
| WO2018075954A2 (en) * | 2016-10-21 | 2018-04-26 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| WO2019024979A1 (en) * | 2017-07-31 | 2019-02-07 | Institute For Research In Biomedicine | FUNCTIONAL DOMAIN ANTIBODIES IN THE ELBOW REGION |
| EA202091521A1 (ru) * | 2017-12-19 | 2020-10-22 | Дзе Рокфеллер Юниверсити | ВАРИАНТЫ ДОМЕНА Fc IgG ЧЕЛОВЕКА С УЛУЧШЕННОЙ ЭФФЕКТОРНОЙ ФУНКЦИЕЙ |
| US20220298230A1 (en) * | 2019-06-11 | 2022-09-22 | The Rockefeller University | Antibodies and methods for treatment of viral infections |
-
2022
- 2022-02-08 CN CN202280027190.9A patent/CN117136197A/zh active Pending
- 2022-02-08 JP JP2023547808A patent/JP7880344B2/ja active Active
- 2022-02-08 BR BR112023015900A patent/BR112023015900A2/pt unknown
- 2022-02-08 WO PCT/US2022/015652 patent/WO2022173745A1/en not_active Ceased
- 2022-02-08 TW TW111104605A patent/TW202246317A/zh unknown
- 2022-02-08 EP EP22706468.0A patent/EP4291575A1/en active Pending
- 2022-02-08 CA CA3210502A patent/CA3210502A1/en active Pending
- 2022-02-08 US US18/264,408 patent/US20240101648A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022137183A5 (enExample) | ||
| Qanungo et al. | Two RNA polymerase complexes from vesicular stomatitis virus-infected cells that carry out transcription and replication of genome RNA | |
| Spriggs et al. | Fusion glycoprotein of human parainfluenza virus type 3: nucleotide sequence of the gene, direct identification of the cleavage-activation site, and comparison with other paramyxoviruses | |
| JP2002513556A5 (enExample) | ||
| JP2008533988A5 (enExample) | ||
| JP2010502207A5 (enExample) | ||
| CN102307896A (zh) | 基于ⅲ型纤连蛋白结构域的支架组合物、方法及用途 | |
| CN115925826B (zh) | 一种抗新型冠状病毒的多肽及其应用 | |
| JP2006525796A5 (enExample) | ||
| JP2008525033A5 (enExample) | ||
| JP2012526542A5 (enExample) | ||
| JP2004531242A5 (enExample) | ||
| JP2011530524A5 (enExample) | ||
| CN115043933B (zh) | 靶向新冠病毒的纳米抗体及其制备方法和应用 | |
| Muniyandi et al. | Structure and function of the human respiratory syncytial virus M2–1 protein | |
| CN120366260A (zh) | Rna聚合酶变体及其应用 | |
| Bando et al. | Molecular cloning and sequence analysis of human parainfluenza type 4A virus HN gene: its irregularities on structure and activities | |
| Gauntt et al. | Inhibition of Mengo virus by interferon | |
| CN115386536B (zh) | 用于培养Vero细胞的化学限定培养基、扩增病毒的方法和制备疫苗的方法 | |
| CN116676312A (zh) | 一种编码A27L保护性抗体的mRNA及其应用 | |
| CN107417788A (zh) | 抗埃博拉病毒的中和性单克隆抗体 | |
| CN1986569A (zh) | 人源抗呼吸道合胞病毒中和性基因工程Fab抗体 | |
| CN119144620B (zh) | 呼吸道合胞病毒mRNA疫苗及其制备方法和应用 | |
| CN121227875B (zh) | 一种抗病毒药物筛选标志物、微粒体甘油三酯转移蛋白抑制剂在制备抗病毒药物中的应用 | |
| CN117379544B (zh) | 一种抗体组合物及其在制备抗新冠病毒的药物中的应用 |